NCT05489731 2023-06-15
VIC-1911
Jiesi Yingda Pharmaceutical Technology (Suzhou) Co., Ltd.
Phase 1 Unknown
Clinical Trials
3 trialsNCT04990063 2021-08-04
Adoptive TKC Transfer Combined With Chemotherapy for Advanced Non-small Cell Lung Cancer (NSCLC)
Tang-Du Hospital
Phase 1 Unknown
NCT03727867 2019-01-30
Efficacy of Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor Combined With Early Stereotactic Body Radiation Therapy to the Primary Tumor in Advanced Non-small Cell Lung Cancer
Taizhou Hospital
Phase 3 Unknown